Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations

Peptides derived from the C-terminal heptad repeat (CHR) of HIV gp41 have been developed as effective fusion inhibitors against HIV-1, but facing the challenges of enhancing potency and stability. Here, we report a rationally designed novel HIV-1 fusion inhibitor derived from CHR-derived peptide (Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yun, Su, Shan, Qin, Lili, Wang, Qian, Shi, Lei, Ma, Zhenxuan, Tang, Jianchao, Jiang, Shibo, Lu, Lu, Ye, Sheng, Zhang, Rongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036048/
https://www.ncbi.nlm.nih.gov/pubmed/27666394
http://dx.doi.org/10.1038/srep31983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036048/
https://www.ncbi.nlm.nih.gov/pubmed/27666394
http://dx.doi.org/10.1038/srep31983

Ejemplares similares